Cytotoxicity micropollutant removal in a crossflow membrane bioreactor

Bioresource Technology

Volumn 102, Issue 6, 2011, Pages 4395-4401

  Delgado, Luis F ^a,c   Faucet Marquis, Virginie ^a   Pfohl Leszkowicz, Annie ^a   Dorandeu, Christophe ^b   Marion, Benedicte ^b   Schetrite, Sylvie ^a   Albasi, Claire ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b UNIV MONTPELLIER   (France)

^c UNIVERSIDAD DE LOS ANDES   (Colombia)

Author keywords

Cyclophosphamide; Cytotoxicity; Membrane bioreactor; Micropollutants; Wastewater

Indexed keywords

AQUEOUS ENVIRONMENT; CROSSFLOW MEMBRANES; CYCLOPHOSPHAMIDE; CYTOSTATIC; HUMIC ACID; MEMBRANE BIOREACTOR; MEMBRANE BIOREACTOR TECHNOLOGY; MICROPOLLUTANTS; OPERATING CONDITION; TERTIARY TREATMENT; TOXIC EFFECT;

BIOCONVERSION; BIOLOGICAL MATERIALS; BIOLOGICAL WATER TREATMENT; CYTOTOXICITY; ENZYME IMMOBILIZATION; ORGANIC ACIDS; WASTEWATER; WASTEWATER TREATMENT;

BIOREACTORS;

ADSORBENT; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; HUMIC ACID;

BIOREACTOR; CYTOLOGY; DRUG; HUMIC ACID; MEMBRANE; POLLUTANT REMOVAL; TOXICITY; WASTEWATER;

ARTICLE; CROSSFLOW FILTRATION; CYTOTOXICITY; ENVIRONMENT; FRESHWATER ENVIRONMENT; MEMBRANE REACTOR; POLLUTANT; PRIORITY JOURNAL; SUPERNATANT; TOXICITY; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT;

BIOREACTORS; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CYCLOPHOSPHAMIDE; HEP G2 CELLS; HUMANS; MEMBRANES, ARTIFICIAL; PERMEABILITY; PILOT PROJECTS; PRESSURE; RHEOLOGY; WATER POLLUTANTS, CHEMICAL;

EID: 79551687401     PISSN: 09608524     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biortech.2010.12.107     Document Type: Article

References (26)

1. Avella A.C., Delgado L.F., Gorner T., Albasi C., Galmiche M., De Donato Ph. Effect of cytostatic drug presence on extracellular polymeric substances formation in municipal wastewater treated by membrane bioreactor. Bioresour. Technol. 2010, 101(2):518-526.
2. Borcherding J., Wolf J. The influence of suspended particles on the acute toxicity of 2-chloro-4-nitro-aniline, cadmium, and pentachlorophenol on the valve movement response of the Zebra mussel (Dreissena polymorpha). Arch. Environ. Contam. Toxicol. 2001, 40:497-504.
3. Buerge I.J., Buser H.R., Poiger T., Müller M.D. Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters. Environ. Sci. Technol. 2006, 40:7242-7250.
4. Clara M., Kreuzinger N., Strenn B., Gans O., Kroiss H. The solids retention time - a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res. 2005, 39:97-106.
5. De Wever H., Weiss S., Reemtsma T., Vereecken J., Müller J., Knepper T., Röden O., Gonzalez S., Barcelo D., Hernando M.D. Comparison of sulfonated and other micropollutants removal in membrane bioreactor and conventional wastewater treatment. Water Res. 2007, 41:935-945.
6. Delgado L.F., Dorandeu C., Marion B., Gonzalez C., Faucet-Marquis V., Schetrite S., Albasi C. Removal of a cytostatic drug by a membrane bioreactor. Desalination Water Treat. 2009, 9:112-118.
7. Delgado Luis F., Faucet-Marquis Virginie, Schetrite Sylvie, Pfohl-Leszkowicz Annie, Paranthoen Sylvia, Albasi Claire Effect of cytostatic drugs on the sludge and on the mixed liquor characteristics of a cross-flow membrane bioreactor: consequence on the process. J. Membr. Sci. 2010, 347(1-2):165-173.
8. Delgado Luis F., Schetrite S., Gonzalez C., Albasi C. Effect of cytostatic drugs on microbial behavior in membrane bioreactor system. Bioresour. Technol. 2010, 101(2):527-536.
9. Dreywood R. Qualitative test for the carbohydrate material. Ind. Eng. Chem. 1946, 18:499.
10. Faucet-Marquis, V., Delgado, L., Dauta, A., Albasi, C., Pfohl-Leszkowicz, A., 2008. Development of biomarkers for following decontamination of water after treatment of hospital water waste by membrane bioreactor process. In: One-day Meeting for UK Molecular Epidemiology Group in Collaboration with ECNIS and NuGO held on 13 December 2007 at Pippard Lecture Theatre, Sherfield Building, South Kensington Campus, Imperial College, London, UK (Mutagenesis, 23, e1-e4).
11. Frolund B., Griebe T., Nielsen O.H. Enzymatic activity in the activated sludge flocs matrix. Appl. Microbiol. Biotechnol. 1995, 43:755-761.
12. Gilard V., Martino R., Malet-Martino M.C., Kutscher B., Müller A., Niemeyer U., Pohl J., Polymeropoulos E.E. Chemical and biochemical evaluation of hydrolysis products of cyclophosphamide. J. Med. Chem. 1994, 37:3986-3993.
13. Johnson Andrew C., Jürgens Monika D., Williams Richard J., Kümmerer Klaus, Kortenkamp Andreas, Sumpter John P. Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study. J. Hydrol. 2008, 348:167-175.
14. Joqueviel C., Martino R., Gilard V., Malet-Martino M., Canal P., Niemeyer U. Urinary excretion of cyclophosphamide in humans, determined by phosphorus-31 nuclear magnetic resonance spectroscopy. Drug Metab. Dispos. 1998, 26(5):418-428.
15. Joss A., Keller E., Alder A.C., Göbel A., McArdell C.S., Ternes T., Siegrist H. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res. 2005, 39:3139-3152.
16. Kümmerer K. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources - a review. Chemosphere 2001, 45:957-969.
17. Kümmerer K., Steger-Hartmann T., Baranyai A., Bürhaus I. Prüfung des biologischen abbaus der Zytostatika Cyclophosphamid und ifosfamide mit dem closed bottle test (OECD 301 D). Zentralbl. Hyg. Umweltmed. 1996, 198:215-225.
18. Larsen T.A., Lienert J., Joss A., Siegrist H. How to avoid pharmaceuticals in the aquatic environment? J. Biotechnol. 2004, 113:295-304.
19. Mahnik S.N., Lenz K., Weissenbacher N., Mader R.M., Fuerhacker M. Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. Chemosphere 2007, 66:30-37.
20. Moore M.J. Clinical pharmacokinetics of cyclophosphamide. Clin. Pharmacokinet. 1991, 20:1994-2008.
21. Ra Jin Sung, Oh Seok-Young, Lee Byung Cheun, Kim Sang Don The effect of suspended particles coated by humic acid on the toxicity of pharmaceuticals, estrogens, and phenolic compounds. Environ. Int. 2008, 34:184-192.
22. Sladek N.E. Metabolism and pharmacokinetic behavior of cyclophosphamide and related oxazaphosphorines. Anticancer Drugs: Reactive Metabolism and Drug Interactions 1994, 79-156. Pergamon Press, Oxford, UK. G. Powis (Ed.).
23. Steger-Hartmann T., Kümmerer K., Hartmann A. Biological degradation of cyclophosphamide and its occurrence in sewage water. Ecotoxicol. Environ. Saf. 1997, 36:174-179.
24. Urase T., Kikuta T. Separate estimation of adsorption and degradation of pharmaceutical substances and estrogens in the activated sludge process. Water Res. 2005, 39(7):1289-1300.
25. Wang L., Albasi C., Faucet-Marquis V., Pfohl-Leszkowicz A., Dorandeu C., Marion B., Causserand C. Cyclophosphamide removal from water by nanofiltration and reverse osmosis membrane. Water Res. 2009, 43(17):4115-4122.
26. Weiss S., Reemtsma T. Membrane bioreactors for municipal wastewater treatment - a viable option to reduce the amount of polar pollutants discharged into surface waters? Water Res. 2008, 42(14):3837-3847.